期刊文献+

舒肝解郁胶囊对伴抑郁症状精神分裂症患者认知功能和生活质量的影响 被引量:4

THE EFFECT OF SHUGANJIEYU CAPSULES ON THE COGNITION AND QUALITY OF LIFE IN TREATMENT SCHIZOPHRENIA WITH DEPRESSION
下载PDF
导出
摘要 目的探讨伴抑郁症状精神分裂症的治疗方法。方法选取首发伴抑郁症状精神分裂症患者56例,将其随机分为两组,各28例。对照组给予利培酮治疗,研究组加用舒肝解郁胶囊治疗,8周后观察两组临床效果。结果研究组总有效率为96.43%,高于对照组的71.43%(χ^(2)=4.77,P=0.029);研究组的认知功能及生活质量改善程度均优于对照组(t=5.24~11.97,P<0.01)。结论舒肝解郁胶囊佐治伴抑郁症状精神分裂症患者,能提高患者认知功能,改善患者生活质量。 Objective To explore the treatment of schizophrenia with depressive symptoms.Methods A total of 56 patients with schizophrenia with depressive symptoms were selected and randomly divided into two groups with 28 cases in each group.The control group was treated with risperidone,and the study group was treated with Shuganjieyu capsule.The clinical effects of the two groups were observed after 8 weeks.Results The total effective rate of the study group was 96.43%,which was higher than 71.43%of the control group(χ^(2)=4.77,P=0.029).The improvement of cognitive function and quality of life of the study group was better than that of the control group(t=5.24-11.97,P<0.01).Conclusion Shuganjieyu Capsule can assist the treatment of patients with schizophrenia with depressive symptoms,which can improve patients'cognitive function and improve their quality of life.
作者 陈久富 傅德香 周攀 陈燕 唐娜 吴清秀 刘东芳 王通收 卢公荣 CHEN Jiu-fu;FU De-xiang;ZHOU Pan(Linshu Country Mental Health Center,Linshu 276700,China)
出处 《山东医学高等专科学校学报》 2021年第2期105-107,共3页 Journal of Shandong Medical College
基金 临沂市科技发展计划项目(No.202020103)。
关键词 舒肝解郁胶囊 抑郁症状 精神分裂症 认知功能 生活质量 Shuganjieyu Capsules Depression symptoms Schizophrenia Cognition function Quality of Life
  • 相关文献

参考文献5

二级参考文献25

  • 1Medalia A, Lim R. Treatment of cognitive dysfunction in psychiatric disorders. J Psychiatr Pract, 2004, 10(1) : 17 -25.
  • 2Randolph C, Tiemey MC, Mohr E, et al. The repeatable battery for the assessment of neuropsychological status ( RBANS ) : preliminary clinical validity. J Clin Exp Neuropsycho, 1998, 20(3) : 310 -319.
  • 3Gold JM, Queern C, Iannone VN, et al. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, Ⅰ : sensitivity, reliability, and validity. Am J Psychiat, 1999, 156(12) : 1944 -1950.
  • 4Hobart MP, Goldberg R, Bartko J J, et al. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, Ⅱ: convergent/discriminant validity and diagnostic group comparisons. Am J Psychiat, 1999, 156(12) : 1951 - 1957.
  • 5World Health Organization. World Health Organization - battery of cognitive assessment instrument for eldly. Geneva WHO, 1996:5 - 8.
  • 6Macleod CM. Half a century of research on the Stroop effect: an integrative review. Psychol Bull, 1991, 109 (2) : 163 - 203.
  • 7Censits DM, Ragland JD, Gur RC, et al. Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study. Schizophr Res, 1997, 24(3) :289 -298.
  • 8Gold JM, Goldberg RW, McNary SW, et al. Cognitive correlates of job tenure among patients with severe mental illness. Am J Psychiat, 2002, 159(8) :1395 - 1402.
  • 9Ganguli R, Brar JS, Vemulapalli H, et al. Mini - mental state examination (MMSE) performance of partially remitted community - dwelling patients with schizophrenia. Schizophr Res, 1998, 33 ( 1 - 2) :45 -52.
  • 10Wilk CM, Gold JM, Humber K, et al. Brief cognitive assessment in schizophrenia: normative data for the repeatable battery for the assessment of neuropsychological status. Schizophr Res, 2004, 70 (2 - 3): 175-186.

共引文献357

同被引文献59

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部